Delivery Order SPE2DB22D1106-SPE2DB23FEEQ4
Award Date 4/21/23
Potential Completion Date 4/24/23
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DB20D2104|SPE2DB24FT93T, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,693.49 delivery order contract is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used for the emergency treatment of opioid overdose. The contract has a firm fixed price pricing type and an ultimate completion date of May 1, 2024. This award is part of a larger Indefinite Delivery...
- This federal contract award, valued at $4,707.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,941,949 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, SPE2DB22D3016|SPE2DB24FAET8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,533.12, is for the delivery of 4562987109 - NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $2,321.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,244,594 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the emergency treatment of opioid overdose. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) with a Firm Fixed Price (FFP) type, valued at $17,468.20. The award is from the Defense Logistics Agency (DLA) for the supply of 4 mg Naloxone Hydrochloride Nasal Spray, a critical medication used to treat opioid overdose. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022. This DO is part of a larger Indefinite Delivery Contract...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,562,139,657 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $1,199.86 and a completion date of September 13, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $12,960.05, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,251,316 units of 4 mg Naloxone HCL nasal spray, a critical medication used to reverse opioid overdoses. This is a firm fixed-price delivery order contract with a completion date of September 21, 2023. The contract was awarded on an open competition basis,...
- This federal contract award, valued at $7,194.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,557,108,798 units of 4 mg Naloxone HCL nasal spray, a medication used to treat opioid overdose. The contract has a completion date of May 5, 2022 and utilizes a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award (SPE2DB20D2104|SPE2DB25FMFLN) was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,687.45 firm fixed-price delivery order is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This federal contract award is a delivery order worth $21,038.11 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,556,232,076 units of Naloxone HCL 4 mg Nasal Spray 2S, a critical medication used for the treatment of opioid overdose. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp...